Adult Acute Megakaryoblastic Leukemia

9 clinical trials · Condition

Record	Firm	Date
Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia (NCT01870596)	National Cancer Institute (NCI)	2013-05-01
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia (NCT01361464)	National Cancer Institute (NCI)	2011-05-01
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia (NCT01260714)	National Cancer Institute (NCI)	2010-12-01
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia (NCT01168219)	National Cancer Institute (NCI)	2010-07-15
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00658814)	National Cancer Institute (NCI)	2008-12-01
Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders (NCT00588991)	National Cancer Institute (NCI)	2008-02-04
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase (NCT00383474)	National Cancer Institute (NCI)	2006-08-01
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission (NCT00093470)	National Cancer Institute (NCI)	2004-08-18

Every clearance here is in the API, with alerts when new ones post.